Details
New companies 3 · Follow-on 0
Stages: Series B 1, Series C+ 1, Undisclosed 1
Abcuro $66M Series DBridge to Life $110M Series C+DebtCrystalys Therapeutics $130M Series BRanked by rounds participated in, from announcements in Jul 20, 2026 – Oct 17, 2026. Lead counts include only confirmed lead roles.
New companies 3 · Follow-on 0
Stages: Series B 1, Series C+ 1, Undisclosed 1
Abcuro $66M Series DBridge to Life $110M Series C+DebtCrystalys Therapeutics $130M Series BNew companies 3 · Follow-on 0
Stages: Undisclosed 2, Seed 1
SpaceAM Undisclosed SeedTidalSense $19M UndisclosedMach42 £7M UndisclosedNew companies 3 · Follow-on 0
Stages: Series A 2, Seed 1
Axle $17.5M Series ASapiom $35M Series ACredible Data $10M SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
CapGrid ₹462.8M Pre-Series BFurnishka ~₹268M Extended pre-Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Estuary Biotherapeutics $93M Series ASuperluminal Medicines $60M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Beff Inc. ~¥300M Series A final closeSpectronix ¥518M Series F extensionNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
MHX Technology CN¥1.6B First equity financing agreementInfiMaker Undisclosed Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Estuary Biotherapeutics $93M Series ACrystalys Therapeutics $130M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Beff Inc. ~¥300M Series A final closeQBITech Co., Ltd. ~¥600M Series BNew companies 2 · Follow-on 0
Stages: Series A 2
Estuary Biotherapeutics $93M Series Aai3Bio $48M Series ANew companies 2 · Follow-on 0
Stages: Series C+ 2
OMass Therapeutics $310M Series CAbcuro $66M Series DNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Origin Undisclosed UndisclosedKheops €12M Series ANew companies 2 · Follow-on 0
Stages: Pre-seed 1, Undisclosed 1
Solvera $6.3M Pre-seedBirdsview NOK 40.5M Funding roundNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Pinpin Kirari ¥50M LoanTHE PHAGE ¥570M Series A first closeNew companies 2 · Follow-on 0
Stages: Undisclosed 2
N.D.Promotion Undisclosed Strategic investmentContents X Undisclosed Strategic equity investmentNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
RevRag AI $2.5M SeedStarcloud $250M Series A extensionNew companies 2 · Follow-on 0
Stages: Series A 2
Spill Games $10.5M Series AMesa School of Business ₹1.1B Series A and venture debtNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
AZOO Undisclosed Series ARege Nephro Co $10.6M Series CNew companies 2 · Follow-on 0
Stages: Series A 2
AZOO Undisclosed Series ABridgeSmile Co., Ltd. ¥819M Series ANew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Salience Labs $125M Series BFasset $68M Series C“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.